Market Research Logo

Heidelberg Pharma AG (WL6) - Financial and Strategic SWOT Analysis Review

Heidelberg Pharma AG (WL6) - Financial and Strategic SWOT Analysis Review

Heidelberg Pharma AG (WL6) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Heidelberg Pharma AG (Heidelberg Pharma) formerly, Wilex AG is a biopharmaceutical company. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. Heidelberg Pharma’s pipeline products are focused on treating multiple myeloma, prostate cancer, hematological cancers, metastatic pancreatic cancers, leukemia, non- metastatic ccRCC, kidney cancers and solid tumors. Through its subsidiaries it also provides preclinical contract research services and an antibody drug conjugate (ADC) technology platform. Heidelberg Pharma is headquartered in Ladenburg, Germany.

Heidelberg Pharma AG Key Recent Developments

Jul 12,2018: Heidelberg Pharma reports on first half -year
Apr 12,2018: Heidelberg Pharma: Interim Management Statement on the First Three Months of 2018
Apr 09,2018: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
Mar 22,2018: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update
Jan 08,2018: Heidelberg Pharma and Advanced Proteome Therapeutics Progress Collaborative Program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Heidelberg Pharma AG - Key Facts
Heidelberg Pharma AG - Key Employees
Heidelberg Pharma AG - Key Employee Biographies
Heidelberg Pharma AG - Major Products and Services
Heidelberg Pharma AG - History
Heidelberg Pharma AG - Company Statement
Heidelberg Pharma AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Heidelberg Pharma AG - Business Description
Heidelberg Pharma AG - Corporate Strategy
Heidelberg Pharma AG - SWOT Analysis
SWOT Analysis - Overview
Heidelberg Pharma AG - Strengths
Heidelberg Pharma AG - Weaknesses
Heidelberg Pharma AG - Opportunities
Heidelberg Pharma AG - Threats
Heidelberg Pharma AG - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Heidelberg Pharma AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 12, 2018: Heidelberg Pharma reports on first half -year
Apr 12, 2018: Heidelberg Pharma: Interim Management Statement on the First Three Months of 2018
Apr 09, 2018: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
Mar 22, 2018: Heidelberg Pharma announces financial figures for fiscal year 2017 and provides business update
Jan 08, 2018: Heidelberg Pharma and Advanced Proteome Therapeutics Progress Collaborative Program
Jul 13, 2017: WILEX reports on first half-year
Apr 12, 2017: WILEX: Interim management statement on the first three months of 2017
Mar 30, 2017: WILEX announces financial figures for the 2016 fiscal year and reports on course of business
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Heidelberg Pharma AG, Key Facts
Heidelberg Pharma AG, Key Employees
Heidelberg Pharma AG, Key Employee Biographies
Heidelberg Pharma AG, Major Products and Services
Heidelberg Pharma AG, History
Heidelberg Pharma AG, Subsidiaries
Heidelberg Pharma AG, Key Competitors
Heidelberg Pharma AG, Ratios based on current share price
Heidelberg Pharma AG, Annual Ratios
Heidelberg Pharma AG, Annual Ratios (Cont...1)
Heidelberg Pharma AG, Interim Ratios
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Heidelberg Pharma AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Heidelberg Pharma AG, Performance Chart (2013 - 2017)
Heidelberg Pharma AG, Ratio Charts
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report